146 related articles for article (PubMed ID: 26039121)
1. High 18F-Fluorodeoxyglucose Uptake in Adrenal Angiomyolipoma: Case Report and Review of Literature.
Li W; Pang H; Cao Y; Guan L; Chen J
Medicine (Baltimore); 2015 Jun; 94(22):e900. PubMed ID: 26039121
[TBL] [Abstract][Full Text] [Related]
2. A case of multiple hepatic angiomyolipomas with high (18) F-fluorodeoxyglucose uptake.
Kumasaka S; Arisaka Y; Tokue A; Higuchi T; Nakajima T; Tsushima Y
BMC Med Imaging; 2014 May; 14():17. PubMed ID: 24885757
[TBL] [Abstract][Full Text] [Related]
3. High False Positivity in Positron Emission Tomography is a Potential Diagnostic Pitfall in Patients with Suspected Adrenal Metastasis.
Lang BH; Cowling BJ; Li JY; Wong KP; Wan KY
World J Surg; 2015 Aug; 39(8):1902-8. PubMed ID: 25809060
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
Stone WZ; Wymer DC; Canales BK
J Endourol; 2014 Jan; 28(1):104-11. PubMed ID: 23927734
[TBL] [Abstract][Full Text] [Related]
5. Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging.
Gratz S; Kemke B; Kaiser W; Heinis J; Behr TM; Höffken H
J Int Med Res; 2010; 38(2):633-44. PubMed ID: 20515577
[TBL] [Abstract][Full Text] [Related]
6. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
[TBL] [Abstract][Full Text] [Related]
8. FDG PET or PET/CT in evaluation of renal angiomyolipoma.
Lin CY; Chen HY; Ding HJ; Yen KY; Kao CH
Korean J Radiol; 2013; 14(2):337-42. PubMed ID: 23483018
[TBL] [Abstract][Full Text] [Related]
9. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
10. [Cavernous hemangioma: rare incidentaloma of the adrenal gland].
de la Villéon B; Goudard Y; Peroux E; Jacquet SF; Aubert P; Duverger V
Prog Urol; 2011 Dec; 21(13):961-4. PubMed ID: 22118362
[TBL] [Abstract][Full Text] [Related]
11. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
12. Hepatic epithelioid angiomyolipoma mimicking hepatocellular carcinoma on MR and
Wang S; Xia H; Liu X; Liu Y; Lou C
Hell J Nucl Med; 2022; 25(2):205-209. PubMed ID: 35913867
[TBL] [Abstract][Full Text] [Related]
13. May an adrenal incidentaloma change its nature?
Müller A; Ingargiola E; Solitro F; Bollito E; Puglisi S; Terzolo M; Pia A; Reimondo G
J Endocrinol Invest; 2020 Sep; 43(9):1301-1307. PubMed ID: 32180166
[TBL] [Abstract][Full Text] [Related]
14. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
15. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
16. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S
Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET and CT characterization of adrenal lesions in cancer patients.
Jana S; Zhang T; Milstein DM; Isasi CR; Blaufox MD
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):29-35. PubMed ID: 16193311
[TBL] [Abstract][Full Text] [Related]
19. Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.
Dong P; Wang L; Shen G; Li L
Medicine (Baltimore); 2019 Mar; 98(11):e14818. PubMed ID: 30882662
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: Response to mammalian target of rapamycin inhibitor therapy.
Anwar H; Sachpekidis C; Schwarzbach M; Dimitrakopoulou-Strauss A
Hell J Nucl Med; 2017; 20(2):169-171. PubMed ID: 28697195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
